Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

65.32USD
2:25pm EST
Change (% chg)

$0.54 (+0.83%)
Prev Close
$64.78
Open
$65.00
Day's High
$65.54
Day's Low
$64.75
Volume
663,665
Avg. Vol
685,846
52-wk High
$66.18
52-wk Low
$43.81

Latest Key Developments (Source: Significant Developments)

Baxter sees Q4 revenue to be negatively impacted by about $70 mln due to temporary manufacturing disruptions resulting from Hurricane Maria​
Wednesday, 25 Oct 2017 07:15am EDT 

Oct 25 (Reuters) - Baxter International Inc :Baxter reports third-quarter 2017 results and updates financial outlook for full-year 2017.Q3 GAAP earnings per share $0.45 from continuing operations.Q3 revenue $2.7 billion versus I/B/E/S view $2.66 billion.Q3 earnings per share view $0.59 -- Thomson Reuters I/B/E/S.Sees Q4 earnings per share $0.56 to $0.59 from continuing operations excluding items.Sees FY 2017 earnings per share $2.40 to $2.43 from continuing operations excluding items.Sees FY 2017 GAAP earnings per share $1.85 to $1.93.Baxter International Inc - ‍qtrly sales within U.S. were approximately $1.1 billion, advancing 8 percent​.Baxter International - Sees Q4 revenue to be negatively impacted by about $70 million due to temporary manufacturing disruptions resulting from Hurricane Maria​.Baxter - Qtrly ‍international sales about $1.6 billion, representing a 5 percent increase on reported basis and a 4 percent increase on a constant currency basis​.Baxter International - ‍For FY 2017, co now expects sales growth of about 4 percent on a reported basis, about 4 percent on a constant currency basis​.Q3 adjusted earnings per share $0.64 from continuing operations excluding items.Baxter International Inc - ‍Remains in limited production across all three manufacturing sites in Puerto Rico​.FY2017 earnings per share view $2.39, revenue view $10.50 billion -- Thomson Reuters I/B/E/S.  Full Article

Baxter provides update on Puerto Rico recovery status post Hurricane Maria
Thursday, 12 Oct 2017 04:15pm EDT 

Oct 12 (Reuters) - Baxter International Inc :Baxter provides update on Puerto Rico recovery status post Hurricane Maria.Baxter International Inc - ‍company expects to mitigate earnings impact from Hurricane Maria​.Baxter International Inc - ‍resumed limited production at all Puerto Rico manufacturing sites​.Baxter International Inc - ‍Baxter's three Puerto Rico manufacturing sites sustained minimal structural damage from impact of Hurricane Maria​.Baxter - co granted discretion for temporary importation of some products from facilities in Ireland, Australia to support product supply for U.S. market​.Baxter International Inc - ‍company does not manufacture large volume sterile solutions, such as its 1 liter IV solutions, in Puerto Rico​.  Full Article

Baxter International Inc - ‍launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System​
Wednesday, 27 Sep 2017 08:00am EDT 

Sept 27 (Reuters) - Baxter International Inc :Baxter International Inc - ‍launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System​.  Full Article

Baxter International ‍announces commercial launch of new indication for oXiris set​
Tuesday, 26 Sep 2017 08:55am EDT 

Sept 26 (Reuters) - Baxter International Inc : :Baxter launches first 3-in-1 set for use in continuous renal replacement therapy and sepsis management protocols.Baxter International Inc - ‍announced commercial launch of a new indication for company's oXiris set​.Baxter International Inc - ‍Baxter currently plans to file for expanded indication for oXiris set in additional countries in 2018 and beyond​.  Full Article

Baxter and MATTER Healthcare on patient-driven innovation
Thursday, 31 Aug 2017 08:30am EDT 

Aug 31 (Reuters) - Baxter International Inc :Baxter and MATTER Healthcare Incubator Partner on patient-driven innovation.Baxter International Inc - ‍ as part of agreement will gain access to MATTER's extensive program suite.​.  Full Article

Baxter reports second-quarter 2017 results
Wednesday, 26 Jul 2017 07:15am EDT 

July 26 (Reuters) - Baxter International Inc :Baxter reports second-quarter 2017 results and provides updated financial outlook for 2017 and 2020.Sees FY 2020 adjusted earnings per share $3.25 to $3.40.Q2 GAAP earnings per share $0.48 from continuing operations.Q2 revenue $2.6 billion versus I/B/E/S view $2.59 billion.Q2 earnings per share view $0.57 -- Thomson Reuters I/B/E/S.Sees FY 2017 earnings per share $2.34 to $2.40 from continuing operations excluding items.Sees Q3 earnings per share $0.58 to $0.60 from continuing operations excluding items.Sees FY 2017 GAAP earnings per share $1.85 to $1.95.Baxter International Inc says financial outlook for 2020 increased to reflect strong operational execution and ongoing business transformation initiatives.Q3 earnings per share view $0.56 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $2.27 -- Thomson Reuters I/B/E/S.Baxter International Inc says Q2 sales within U.S. were $1.1 billion, advancing 4 percent.Baxter International Inc - for FY2017 raising financial outlook for year and now expects sales growth of approximately 3 percent on a reported basis.Company expects sales growth of approximately 4 percent on a reported basis for Q3.Baxter - Q2 international sales totaled about $1.5 billion, representing a 2 percent decrease on reported basis and 1 percent increase on a constant currency basis.Baxter International Inc - expects sales to grow approximately 4 percent on a compounded annual basis from 2016 to 2020.  Full Article

Baxter, Ramot at Tel Aviv university and Tel Aviv Sourasky Medical Center partner to bring new surgical innovations worldwide
Thursday, 6 Jul 2017 08:00am EDT 

July 6 (Reuters) - Baxter International Inc ::Baxter, Ramot at Tel Aviv University and Tel Aviv Sourasky medical center partner to bring new surgical innovations worldwide.Baxter International Inc says additional details of agreements were not disclosed.Baxter -under terms, will exclusively license TAU technology innovation momentum fund technology in one license agreement.Baxter -under terms, will exclusively TAU and TASMC technology in second license agreement.  Full Article

Baxter announces agreement with Dorizoe Lifesciences to further expand generic injectables pipeline
Wednesday, 14 Jun 2017 08:30am EDT 

June 14 (Reuters) - Baxter International Inc :Baxter announces agreement with dorizoe lifesciences to further expand generic injectables pipeline.Baxter International inc says financial terms of agreement were not disclosed.Baxter -dorizoe will work with baxter to perform certain product development activities, and baxter will hold worldwide manufacturing and commercialization rights.  Full Article

Baxter announces U.S. FDA approval, commercial launch of ready-to-use clindamycin injection in saline
Wednesday, 7 Jun 2017 11:00am EDT 

June 7 (Reuters) - Baxter International Inc :Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline.Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline.Baxter International - FDA approval and commercial launch of ready-to-use clindamycin injection in saline in three commonly prescribed formulations.Baxter International Inc- remains committed to providing additional premixes in an effort to advance pharmacy efficiency and patient care..Baxter International Inc - Baxter's ready-to-use clindamycin injection in saline is now available to customers in United States.  Full Article

Baxter and Mayo Clinic launch R&D collaboration to transform patient care
Wednesday, 31 May 2017 09:15am EDT 

May 31 (Reuters) - Baxter International Inc :Baxter and Mayo Clinic launch research and development collaboration to transform patient care.Baxter International Inc - ‍additional details of agreement were not disclosed​.Baxter International Inc - initial agreement is for a five-year period, with a five-year renewal option.  Full Article

Baxter expects $70 million hit to fourth-quarter sales from Hurricane Maria

U.S. hospital products maker Baxter International Inc on Wednesday forecast a nearly $70 million hit to its fourth-quarter revenue, due to manufacturing disruptions arising from Hurricane Maria.